ES2079063T3 - Utilizacion de analogos de vitamina d en el tratamiento del acne. - Google Patents

Utilizacion de analogos de vitamina d en el tratamiento del acne.

Info

Publication number
ES2079063T3
ES2079063T3 ES91905594T ES91905594T ES2079063T3 ES 2079063 T3 ES2079063 T3 ES 2079063T3 ES 91905594 T ES91905594 T ES 91905594T ES 91905594 T ES91905594 T ES 91905594T ES 2079063 T3 ES2079063 T3 ES 2079063T3
Authority
ES
Spain
Prior art keywords
vitamin
acne
treatment
analogs
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91905594T
Other languages
English (en)
Inventor
Wagn Ole Godtfredsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Application granted granted Critical
Publication of ES2079063T3 publication Critical patent/ES2079063T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)

Abstract

LA INVENCION SE REFIERE AL USO DE CIERTOS ANALOGOS DE LA VITAMINA D EN LA PREPARACION DE UN COMPUESTO FARMACEUTICO PARA EL TRATAMIENTO DEL ACNE. EL COMPUESTO CONTIENE UN ANALOGO DE LA VITAMINA D QUE TIENE SOLAMENTE UNA ACTIVIDAD MODERADA SOBRE EL METABOLISMO DEL CALCIO CUANDO SE COMPARA CON 1, 25 PERO CONSERVA LA CAPACIDAD DE ACTIVAR LOS RECEPTORES PARA 1, 25(OH)2D3 NO ASOCIADO CON LA ABSORCION DE CALCIO O CON LA MOVILIZACION DEL CALCIO DE LOS HUESOS.
ES91905594T 1990-03-01 1991-02-25 Utilizacion de analogos de vitamina d en el tratamiento del acne. Expired - Lifetime ES2079063T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909004544A GB9004544D0 (en) 1990-03-01 1990-03-01 Novel treatment ii

Publications (1)

Publication Number Publication Date
ES2079063T3 true ES2079063T3 (es) 1996-01-01

Family

ID=10671792

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91905594T Expired - Lifetime ES2079063T3 (es) 1990-03-01 1991-02-25 Utilizacion de analogos de vitamina d en el tratamiento del acne.

Country Status (11)

Country Link
US (1) US5292727A (es)
EP (1) EP0517797B1 (es)
JP (1) JPH05504959A (es)
AT (1) ATE127691T1 (es)
AU (1) AU7458891A (es)
DE (1) DE69113029T2 (es)
DK (1) DK0517797T3 (es)
ES (1) ES2079063T3 (es)
GB (1) GB9004544D0 (es)
GR (1) GR3017413T3 (es)
WO (1) WO1991012807A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362719A (en) * 1990-03-01 1994-11-08 Leo Pharmaceutical Products, Ltd. A/S Lovens Kemiske Fabrik Produktionsaktieselskab) Use of vitamin-D analogues in the treatment of acne
USRE39706E1 (en) * 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
PE28297A1 (es) * 1995-01-26 1997-08-20 Hoffmann La Roche Empleo dermatologico de derivados de vitamina d
EP0835853A1 (fr) * 1996-10-14 1998-04-15 Societe Europeenne De Propulsion Elément de friction en matériau composite carbone/carbone-carbure de silicium et procédé pour sa fabrication
JP4387465B2 (ja) 1997-12-09 2009-12-16 中外製薬株式会社 ビタミンｄ３誘導体を含有するローション剤
US6491936B1 (en) 1997-12-09 2002-12-10 Chugai Seiyaku Kabushiki Kaisha Creams containing vitamin D3 derivatives
KR20010032892A (ko) * 1997-12-09 2001-04-25 나가야마 오사무 비타민 ｄ３유도체를 함유하는 크림제
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
CN1173703C (zh) * 1999-04-23 2004-11-03 里奥药物制品有限公司 药物组合物
DE60045101D1 (de) * 1999-08-31 2010-11-25 Chugai Pharmaceutical Co Ltd Weichkapseln
RU2186269C2 (ru) * 2000-02-25 2002-07-27 Дальневосточная государственная морская академия им. адмирала Г.И. Невельского Способ получения антифрикционного покрытия на тонкостенных стальных вкладышах опор скольжения
CN1449289A (zh) * 2000-08-30 2003-10-15 中外制药株式会社 Oct制剂
US7351869B2 (en) * 2002-11-18 2008-04-01 Teva Pharmaceutical Industries Ltd Crystallization method for purification of calcipotriene
GB0307865D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
US7205006B2 (en) * 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
DE602005020842D1 (de) * 2004-11-22 2010-06-02 Wisconsin Alumni Res Found 17,20(e)-dehydro-vitamin-d-analoga und deren verwendungen
ES2447301T3 (es) 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Formulación vitamínica
WO2006138056A1 (en) * 2005-06-15 2006-12-28 Apollo Pharmaceutical, Inc. Pharmaceutical composition comprising a mahonia aquifolium extract for the treatment of psoriasis
PT3095447T (pt) 2006-02-03 2022-01-24 Opko Renal Llc Tratamento da insuficiência e deficiência de vitamina d com 25-hidroxivitamina d2 e 25-hidroxivitamina d3
DK2037936T3 (da) 2006-06-21 2014-09-22 Opko Renal Llc Fremgangsmåde til behandling og forebyggelse af sekundær hyperparathyroidisme
BRPI0715636A2 (pt) * 2006-08-29 2013-07-02 Teva Pharma composiÇÕes farmacologicamente ativas estÁveis incluindo compostos contendo vitamina d e corticosteràide com compatibilidade para ph baixo
US20100273748A1 (en) * 2006-09-08 2010-10-28 The Regents Of The University Of California Antimicrobial therapy
WO2008065514A2 (en) * 2006-11-29 2008-06-05 Glenmark Pharmaceuticals Limited Pharmaceutical compositions containing anhydrous calcipotriene
KR101691876B1 (ko) 2007-04-25 2017-01-02 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
CA2683628C (en) 2007-04-25 2018-03-06 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
ES3047207T3 (en) 2007-04-25 2025-12-03 Opko Renal Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
EP2148685A4 (en) 2007-04-25 2010-07-28 Cytochroma Inc METHODS AND COMPOUNDS FOR THERAPY BASED ON VITAMIN D
US7727562B2 (en) * 2007-06-21 2010-06-01 Blackman Steven T Liquid compositions containing solubilized benzoyl peroxide
ES2593356T3 (es) 2008-04-02 2016-12-07 Opko Ireland Global Holdings, Ltd. Métodos, composiciones, usos y kits útiles para la deficiencia de la vitamina D y trastornos relacionados
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
JP5652723B2 (ja) * 2012-08-17 2015-01-14 フォーモサ・ラボラトリーズ・インコーポレーテッド マキサカルシトールの新しい結晶形態
JP2014144929A (ja) * 2013-01-29 2014-08-14 Daiichi Sankyo Healthcare Co Ltd ビタミン類を含有するニキビの予防又は治療用組成物
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
KR20180123100A (ko) 2016-03-28 2018-11-14 옵코 아일랜드 글로벌 홀딩스 리미티드 비타민 d 치료 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
WO1986005395A1 (fr) * 1985-03-14 1986-09-25 Chugai Seiyaku Kabushiki Kaisha Composition de traitement de dermatoses
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
DE69005897D1 (de) * 1989-05-18 1994-02-24 Hoffmann La Roche Dehydrocholecalciferolderivate.

Also Published As

Publication number Publication date
AU7458891A (en) 1991-09-18
JPH05504959A (ja) 1993-07-29
DE69113029D1 (de) 1995-10-19
WO1991012807A1 (en) 1991-09-05
ATE127691T1 (de) 1995-09-15
EP0517797A1 (en) 1992-12-16
US5292727A (en) 1994-03-08
DE69113029T2 (de) 1996-03-07
EP0517797B1 (en) 1995-09-13
DK0517797T3 (da) 1995-11-13
GB9004544D0 (en) 1990-04-25
GR3017413T3 (en) 1995-12-31

Similar Documents

Publication Publication Date Title
AR042262A2 (es) Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
DK0517797T3 (da) Anvendelse af D-vitaminanaloger i behandlingen af akne
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
ES2125377T3 (es) Azaheterociclicos triciclicos n-acilatados utiles como antagonistas de vasopresina.
ES2157958T3 (es) Uso de venlafaxina o de un compuesto de ariloxipropanamina para la preparacion de un medicamento para el tratamiento de la incontinencia urinaria.
AR062931A2 (es) Compuestos que se enlazan a y activan un receptor de la trombopoyetina , composicones farmaceuticas que los contienen y su uso para la preparacion de medicamentos
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
MX9204354A (es) Compuestos heterociclicos de 5 miembros, procedimiento para prepararlos y composiciones farmaceuticas que los contienen.
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
ES2152966T3 (es) Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion.
ECSP034830A (es) Derivados sustituidos de la ciclohexano-1,4- diamina
ES2170460T3 (es) Compuestos triaromaticos, composiciones que los contienen y utilizaciones.
ES2090303T3 (es) Uso de inositolfosfatos para preparar medicamentos.
MX9203972A (es) Compuestos inhibidores de la proteasa codificada por el virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulado farmaceutico que los contiene.
ES2183180T3 (es) Nuevos derivados de guanidina, procedimientos para su preparacion y su uso como medicamento.
ES2192668T3 (es) Compuestos biciclicos-aromaticos.
UY26370A1 (es) "imidazo-5-il-aminas bicíclicas, medicamentos que las contienen, su uso para la preparación de medicamentos y procedimiento para su preparación".
AR025052A1 (es) Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos.
ES2086771T3 (es) Composicion dermatologica y/o cosmetologica que contiene retinoides.
PA8532001A1 (es) Bifenilcarboxamidas utiles como agentes reductores de lipidos
ES2119326T3 (es) Compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2076595T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su empleo y agentes que los contienen.
ES2098485T3 (es) Complejo que contiene el factor de coagulacion ix.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 517797

Country of ref document: ES